Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

LifeMD: Moving Towards Profitability [Seeking Alpha]

LifeMD, Inc. (LFMD) 
Company Research Source: Seeking Alpha
GLP-1 drugs like Zepbound and Wegovy have helped turbocharge growth in LifeMD's weight management business. The company is delivering impressive and consistent sales growth and is projected to be profitable by FY2025. An updated analysis around LifeMD is presented in the paragraphs below. We last revisited LifeMD, Inc. ( NASDAQ: LFMD in July 2023. The shares of this direct-to-patient telehealth platform have been volatile since then. Recently, they have pulled back some 50% from recent highs, but still have more than tripled over the past year. Where do Recommended For You Recommended For You About LFMD Stock Show less Read more
Impact Snapshot
Event Time:
LFMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for LFMD alerts
Opt-in for
LFMD alerts

from News Quantified
Opt-in for
LFMD alerts

from News Quantified